H. Lenk - Concepedia

Author

H. Lenk

Also Known As

Arbeitsgruppe deutscher Hämophiliebehandler, H Lenk, H. LENK, H. Lenk, HARALD LENK, Harald Lenk, Lenk Harald, Lenk, Harald, M. von Depka Prondzinski

Publications

831

Citations

H-Index

Concepts

All Affiliations

University Hospital Leipzig Leipzig University Goethe University Frankfurt University of Bonn Prof. Hess Kinderklinik

About

H. Lenk is an author at University Hospital Leipzig specializing in hematology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	421
2	Health Sciences	5	5	272
3	Allergy	3	3	224
4	Public Health	1	1	34
5	Emergency Medicine	1	1	34

H. Lenk

Publications

727

Citations

H-Index

Page 1

	Year	Citations
The German Registry of immune tolerance treatment in hemophilia--1999 update. H. Lenk PubMed ImmunohematologyImmune ToleranceImmunologyHigh TiterImmunotherapy	2000	123
Health status and health‐related quality of life of children with haemophilia from six West European countries A. Gringeri, Sylvia von Mackensen, Günter Auerswald, Haemophilia	2004	111
Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J G Gilles, B Desqueper, H. Lenk, Journal of Clinical Investigation ImmunohematologyImmunologyImmunotherapyViii InhibitorsHematology	1996	86
Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates Ch. von Auer, Johannes Oldenburg, M Prondzinski Von Depka, Annals of the New York Academy of Sciences ThrombosisHeme HomeostasisInhibitor DevelopmentBlood TransfusionPharmacology	2005	55
Impact of inhibitor epitope profile on the neutralizing effect against plasma‐derived and recombinant factor VIII concentrates <i>in vitro</i> Jan Astermark, Jan Voorberg, H. Lenk, Haemophilia	2003	49
Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany G. Auerswald, M. von Depka Prondzinski, B. Ehlken, Haemophilia	2004	45
Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function Vytautas Ivaškevičius, Arijit Biswas, Carville G. Bevans, Haematologica	2010	45
The German National Immune Tolerance Registry, 1997 Update H. Lenk Vox Sanguinis ImmunohematologyImmune ToleranceImmunodeficienciesImmunologyPharmacotherapy	1999	38
Inhibitors in German Hemophilia A Patients Treated with a Double Virus Inactivated Factor VIII Concentrate Bind to the C2 Domain of FVIII Light Chain R Laub, Di Giambattista, Pierre Fondu, Thrombosis and Haemostasis Immunocytochemical TechniqueFviii Light ChainImmunologyImmunotherapyC2 Domain	1999	37
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO<sup>®</sup>) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria H. Pöllmann, D. EXTERNEST, Arnold Ganser, Haemophilia Recombinant Factor ViiiLogistic AnalysisInterim DataThrombosisHematology	2007	34

Page 1